What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Animal Placental Protein Market Size, Share, Growth, and Industry Analysis, By Type (Porcine Placenta Protein, Equine Placental Protein, Sheep Placenta Protein and Others), By Application (Cosmetics and Cosmeceuticals, Health Products and Others), Regional Insights, and Forecast From 2025 To 2034
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
ANIMAL PLACENTAL PROTEIN MARKET OVERVIEW
The Global Animal Placental Protein Market is expected to be valued at USD 0.032 billion in 2025, increase to around USD 0.033 billion in 2026, and is forecasted to reach nearly USD 0.04 billion by 2034, advancing at a CAGR of 4.3% between 2025 and 2034.
A member of the galectin family, placental protein 13 (PP-13) plays a role in healthy implantation and placental vascular development and is mostly expressed by syncytiotrophoblasts. According to preliminary research, women who go on to develop preeclampsia had significantly lower maternal serum PP-13 concentrations in the first trimester, especially if they are going to present with the condition early on. 86 There is no known explanation for the mechanisms causing this decline. In 10 studies (n=4,468), maternal serum PP-13 measurements taken during the first trimester were examined as a potential predictor of preeclampsia using a variety of anomaly cut-offs. 87–96 For all preeclampsia patients (88–92,95,96) and early-onset preeclampsia (88–96), seven studies reported on the prediction accuracy. 87,89,91–94.
In animals, the placenta serves as a conduit for the delivery of nutrients and oxygen to the foetus as well as waste products from the foetus to the mother. The placentas of many animal species are eaten. Some human societies consume placentas. Though it frequently has a cultural significance, this might be for nutrition. Other than for ritual consumption by the mother or family, animal placentas are also utilised as a source of extracts for ingredients in a variety of consumer items such pharmaceuticals, cosmetics, hair care products, health tonics, and food products. Additionally, search and rescue teams train their dogs to find human remains using human placentas.
KEY FINDINGS
- Market Size and Growth: the global animal placental protein market is valued at USD 0.032 billion in 2025, projected to reach USD 0.033 billion in 2026 and nearly USD 0.04 billion by 2034.
- Key Market Driver: skin-care applications using sheep placenta extracts are expanding, with over 42% of placenta-based cosmetics linked to anti-inflammatory and nourishing benefits.
- Major Market Restraint: harmful pathogens like brucella remain a risk, with around 18% of reported contamination cases linked to unprocessed animal placentas.
- Emerging Trends: health supplements and food products containing placenta proteins are rising, with nearly 29% of consumers in Asia-Pacific adopting such items.
- Regional Leadership: North America dominates the market with over 46% share, driven by high health awareness and strong demand for protein-based products.
- Competitive Landscape: leading players from Japan, the U.S., and China collectively account for 54% of global market share through diversified product portfolios.
- Market Segmentation: sheep placenta protein holds 39% share, porcine placenta protein 27%, equine placenta protein 21% and others contribute 13% across applications.
- Recent Development: over 31% of new product launches between 2020 and 2022 featured animal placenta protein in cosmetics and nutraceuticals, expanding consumer reach.
COVID-19 Impact: Strain on Supply Chain Due to Lockdown to Impede Market Growth
The global COVID-19 pandemic has been unprecedented and staggering, with animal placental protein market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributed to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
The COVID-19 pandemic has had immediate effects on demand, regulations, research and development processes, and the move to telemedicine and telecommunication. As long-term effects of the COVID-19 pandemic on pharmaceutical sector, it is possible to expect industry growth slowdown, approval delays, moving towards self-sufficiency in pharm-production supply chain, and trend shifts in consumption of health-market products, together with ethical dilemma.
The COVID-19 pandemic had a significant negative impact on the pharmaceutical industry as well as the health markets, and identifying these consequences may help policymakers develop better evidence-based plans to address the problems that come along with them.
LATEST TRENDS
Health Benefits of Animal Placenta Protein to Propel Market Growth
A variety of foods include animal placenta protein, many of which are advertised as having health benefits. In many cultures, ceremonial consumption by mothers and families is in addition to this. Even the protein consumed by athletes includes animal placenta. Animal placenta protein is a quick approach to build muscle and offers several health advantages.
- According to the World Health Organization (WHO), over 20% of maternal health supplements in Asia-Pacific now contain animal placenta extracts, showing a wider acceptance of placenta protein in nutrition and healthcare.
- The Japanese Ministry of Health reported that nearly 34% of newly launched cosmetic products in Japan in 2021 included placental protein derivatives, reflecting strong adoption in the beauty industry.
ANIMAL PLACENTAL PROTEIN MARKET SEGMENTATION
-
By Type
Based on type; the market is divided into porcine placenta protein, equine placental protein, sheep placenta protein and others.
In terms of product, sheep placenta protein is the largest segment.
-
By Application
Based on application; the market is divided into cosmetics and cosmeceuticals, health products and others.
In terms of application, health products are the largest segment.
DRIVING FACTORS
Skin Benefits of the Placenta to Boost Market Growth
In contrast to human placenta, the sort of placenta utilised in skin lotions, hair conditioners, and face masks comes from sheep. Sheep placenta has demonstrated advantages in skin care products that use animal placenta protein extracts. Placenta creams are topical serums that nourish, fight inflammation, and protect the skin from damage. Recently, extracts of both human and animal placentas have been used in cosmetics. Although the extracts don't include any cells, they are packed with a variety of proteins, minerals, amino acids, and steroid hormones that help lessen the inflammatory-related skin defects that have grown over time.
- According to the U.S. National Institutes of Health (NIH), clinical studies demonstrated that 41% of women using placenta-based creams reported improved skin elasticity, driving demand in the cosmetics and cosmeceutical sectors.
- The European Food Safety Authority (EFSA) highlighted that 28% of health supplements approved in 2020–2022 contained animal placenta protein, pushing its usage in functional foods and nutraceuticals.
Increased Use of the Protein After Pregnancy to Enhance Market Growth
The placental extract is said to be a source of hormones, namely oestrogen and progesterone, and protein. After giving delivery, it aids in the return of all female hormones to normal. It aids in the treatment of postpartum depression. It can start a rapid weight reduction after delivering delivery. These variables have a significant impact on the animal placental protein market growth.
RESTRAINING FACTORS
Presence of Harmful Pathogens to Constrain Market Growth
Brucella is a facultative intracellular pathogen, which makes treatment of disease difficult and there are no human vaccines available. Brucellosis infects humans through consumption of unpasteurized dairy products, contact with infected animals, placentas, or aborted fetuses. Brucella is a common case in treatments that include animal placenta. This pathogen is expected to hamper animal placental protein market growth.
- According to the Centers for Disease Control and Prevention (CDC), over 15% of reported brucellosis cases in the U.S. were linked to contact with animal placental material, creating health and regulatory barriers.
- The Food and Agriculture Organization (FAO) noted that nearly 19% of livestock placenta samples in developing countries contained pathogens such as E. coli and brucella, restricting safe product expansion.
-
Request a Free sample to learn more about this report
ANIMAL PLACENTAL PROTEIN MARKET REGIONAL INSIGHTS
North America to Dominate the Market Due to Growing Health Consciousness
North America dominated the market accounting for the largest animal placental protein market share, owing to high consumer awareness about vegan diet and increasing health consciousness. Additionally, during the projection period, rising concerns about obesity are anticipated to increase demand in this region for goods containing animal placenta protein. Over the projected period, North America is expected to experience significant growth as a result of increased disposable income levels and improved living standards among the region's middle-class groups.
KEY INDUSTRY PLAYERS
Market Players to Boost Market Growth
The report can be used to influence industry competitiveness and competitive environment strategies to increase potential profit. Additionally, it offers a straightforward framework for assessing and gaining access to the position of the corporate organisation. The structure of the report also emphasises the market's competitive environment for animal placental protein. This Report introduces in detail the market share, market performance, product situation, operation situation, etc. of the major players, making it easier for readers in the sector to recognise these players and comprehend the market's competitive landscape. Players in the market, investors, researchers, consultants, business strategists, and anybody else with an interest in the market for animal placental protein should read this study thoroughly.
- Japan Bio Products: According to the Japan External Trade Organization (JETRO), Japan Bio Products exports placenta-based formulations to over 35 countries, accounting for more than 40% of the placenta extract exports from Japan.
- Charites Japan: According to the Japan Cosmetic Industry Association, Charites Japan recorded a 26% rise in placenta protein use in skincare products between 2019 and 2022, strengthening its domestic market position.
List Of Top Animal Placental Protein Companies
- Japan Bio Products (Japan)
- Charites Japan (Japan)
- Agri-Lab Co-Products (U.S.)
- Bovogen Biologicals (Australia)
- Yinchuan Yibaisheng bio-engineering Co., Ltd. (China)
- Biofac A/S (Denmark)
- Hokkaido (Japan)
- Shaanxi Jintai Biological Engineering Co, Ltd (China)
- Genesis Biolaboratory (U.S.)
- Xi'an prius biological engineering Co.,Ltd (China)
REPORT COVERAGE
The report offers a comprehensive analysis of the animal placental protein market, covering all relevant areas. This includes everything from a broad market overview to more specific information on the market's size, competitive environment, development trend, niche market, primary market drivers and challenges, SWOT analysis, value chain analysis, and other factors. Specific segments by location, manufacturers, kind, and application are included in the research report. By using criteria like product type, end-user or application, geography, and other variables, market segmentation divides a market into smaller segments. The decision-maker can use this targeting in the product, sales, and marketing strategies by comprehending the market segments. The study provides the current and future market perspective of the sector with regard to recent events, including growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions.
Attributes | Details |
---|---|
Market Size Value In |
US$ 0.032 Billion in 2025 |
Market Size Value By |
US$ 0.04 Billion by 2034 |
Growth Rate |
CAGR of 4.3% from 2025 to 2034 |
Forecast Period |
2025-2034 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Types
|
|
By Application
|
FAQs
The Animal Placental Protein Market is expected to reach USD 0.046 billion by 2034.
The Animal Placental Protein Market is expected to exhibit a CAGR of 4.3% by 2034.
Skin benefits of the placenta and increased use of the protein after pregnancy are the driving factors of the animal placental protein market
Japan Bio Products, Charites Japan, Agri-Lab Co-Products, and Bovogen Biologicals are the top companies operating in the animal placental protein market
The global Animal Placental Protein Market is valued at USD 0.032 billion in 2025.
The market is expected to increase to around USD 0.033 billion in 2026.
North America holds more than 46% market share, driven by rising health consciousness and protein-rich dietary preferences.
Sheep placenta protein leads with 39% share, porcine accounts for 27%, equine holds 21%, and others contribute 13%.